LANDOS BIOPHARMA
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.The company's therapeutics are novel, locally-acting small molecules targeting inflammatory bowel disease (IBD), crohn's disease (CD) and ulcerative colitis (UC), enabling healthcare providers to cure their patients.
LANDOS BIOPHARMA
Industry:
Biopharma Biotechnology Clinical Trials Health Care Pharmaceutical Therapeutics
Founded:
2017-06-01
Address:
Blacksburg, Virginia, United States
Country:
United States
Website Url:
http://www.landosbiopharma.com
Total Employee:
11+
Status:
Active
Contact:
(540) 218-2232
Email Addresses:
[email protected]
Total Funding:
70 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Chris Garabedian
Chris Garabedian investment in Series B - Landos Biopharma
Perceptive Advisors
Perceptive Advisors investment in Series B - Landos Biopharma
PBM Capital Group
PBM Capital Group investment in Series B - Landos Biopharma
RTW Investments LLC
RTW Investments LLC investment in Series B - Landos Biopharma
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Landos Biopharma
Helicase Venture
Helicase Venture investment in Series B - Landos Biopharma
Perceptive Advisors
Perceptive Advisors investment in Series A - Landos Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-21 | Landos Names Gregory Oakes President and Chief Executive Officer |
Official Site Inspections
http://www.landosbiopharma.com Semrush global rank: 4.94 M Semrush visits lastest month: 1.74 K
- Host name: 159.180.132.176
- IP address: 159.180.132.176
- Location: North Chicago United States
- Latitude: 42.325
- Longitude: -87.8561
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60064
